Development of novel therapeutic agents is needed to address the problems of locally recurrent, metastatic, and advanced hormone-refractory prostate cancer. We have constructed a novel complex ...
This is a preview. Log in through your library . Abstract In earlier studies, we identified short (6- to 22-nt) sequences that functioned as internal ribosome entry sites (IRESes) and enhanced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback